SUSSAN ONONAKU: Open Payments
NPI 1982029203 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 38 payments from 6 companies in 2025. Trend: 2023 $361 · 2024 $1,049 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $467 |
| ABBVIE INC. | 14 | $290 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $25 |
Products named: CAPLYTA, VRAYLAR, REXULTI, FANAPT, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
